Document is current
Any future updates will be listed below
-
Authors
Renner, Tyler M.
Stuible, Matthew
Rossotti, Martin A.
Rohani, Nazanin
Cepero-Donates, Yuneivy
Sauvageau, Janelle https://orcid.org/0000-0001-7476-8424
Deschatelets, Lise
Dudani, Renu
Harrison, Blair A.
Baardsnes, Jason
Koyuturk, Izel
St. Michael, Frank
Hill, Jennifer J.
Hemraz, Usha D.
Lenferink, Anne E. G.
Tanha, Jamshid
Fernandes, Barbara
Roldao, Antonio
McCluskie, Michael J.
Akache, Bassel
Durocher, Yves https://orcid.org/0000-0002-2268-4111
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 28 March 2025
First Online: 11 April 2025
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: B.A., U.H., and M.J.M. are inventors on an SLA archaeosome-related patent application. Y.D. is an inventor on a patent application related to the SmT1 antigen (publication number 20230174591). M.A.R. and J.T. are inventors on a patent application (PCT/IB2022/053756) that includes the SARS-CoV-2 spike protein-specific VHHs described here. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
